Altria has touted the deal with Juul as further helping the company move adult smokers to products that may carry less health risk, such as a device called IQOS that Altria is seeking FDA clearance to sell. At the time of the Altria-Juul deal, executives said if concerns about youth smoking aren’t resolved, it could put the entire vaping business at risk, even for adults.
Read More